|
Total tested with RDT
|
198,382
|
136,266
|
17,658
|
|
RDT positive
|
161,052 (81.2%)
|
113,875 (83.6%)
|
11,463 (64.9%)
|
|
RDT positive treated with ACT
|
159,279 (98.9%)
|
112,490 (98.8%)
|
11,372 (99.2%)
|
|
RDT positive treated with rectal artesunate
|
2378 (1.5%)
|
2165 (1.9%)
|
14 (0.1%)
|
|
RDT positive treated with ACT/rectal artesunate
|
159,695 (99.2%)
|
112,864 (99.1%)
|
11,378 (99.3%)
|
|
RDT negative
|
37,330 (18.8%)
|
22,391 (16.4%)
|
6195 (35.1%)
|
|
RDT negative treated with ACT
|
439 (1.2%)
|
263 (1.2%)
|
59 (1.0%)
|
|
RDT negative treated with rectal artesunate
|
299 (0.8%)
|
252 (1.1%)
|
2 (0.03%)
|
|
RDT negative treated with ACT/rectal artesunate
|
737 (2.0%)
|
514 (2.3%)
|
61 (1.0%)
|
